Mankind Pharma Shares Surge 8% After Q2 Earnings Beat
Mankind Pharma shares rose more than 8% intraday on Tuesday, October 27, their biggest single-day gain in nearly two weeks. JPMorgan maintained its neutral rating and Rs 2,700 target.
JPMorgan maintains its ‘neutral’ rating and target price of Rs 2,700, implying a potential downside of 15.9 per cent from Monday’s closing levelShares of Mankind Pharma surged more than 8 per cent during intraday trade on Tuesday, October 27, marking the stock’s biggest single-day gain in nearly tw…